Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients

(2016) Florence Pache et al.   Journal of Neuroinflammation

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome

(2016) Sven Jarius et al.   Journal of Neuroinflammation

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

(2016) Sven Jarius et al.   Journal of Neuroinflammation

Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in ‘pattern II multiple sclerosis’ and brain biopsy findings in a MOG-IgG-positive case

(2016) Sven Jarius et al.   Multiple Sclerosis Journal

Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in ‘pattern II multiple sclerosis’ and brain biopsy findings in a MOG-IgG-positive case

(2016) Sven Jarius et al.   Multiple Sclerosis Journal

Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis

(2015) Reza Khorooshi et al.   ACTA NEUROPATHOLOGICA

Pathologic and Protective Roles for Microglial Subsets and Bone Marrow- and Blood-Derived Myeloid Cells in Central Nervous System Inflammation

(2015) Agnieszka Wlodarczyk et al.   Frontiers in Immunology

Antibodies against interferon-beta in neuromyelitis optica patients

(2014) Nasrin Asgari et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Interferon Alpha Association with Neuromyelitis Optica

(2013) Nasrin Asgari et al.   Clinical & Developmental Immunology

Neuromyelitis optica-like pathology is dependent on type I interferon response

(2013) Reza Khorooshi et al.   EXPERIMENTAL NEUROLOGY

Interferons in the central nervous system: A few instruments play many tunes

(2013) Trevor Owens et al.   GLIA

MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies

(2013) Nicolas Molnarfi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid

(2012) Nasrin Asgari et al.   JOURNAL OF NEUROIMMUNOLOGY

Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?

(2012) Su-Hyun Kim et al.   Multiple Sclerosis Journal

Myelin-reactive antibodies mediate the pathology of MBP–PLP fusion protein MP4-induced EAE

(2011) Stefanie Kuerten et al.   CLINICAL IMMUNOLOGY

Antibody response in MOG35–55 induced EAE

(2011) Patrice H. Lalive et al.   JOURNAL OF NEUROIMMUNOLOGY

Interferon Beta Treatment in Neuromyelitis Optica

(2010) Jacqueline Palace et al.   ARCHIVES OF NEUROLOGY

Interferon-β1b Treatment in Neuromyelitis Optica

(2009) Masami Tanaka et al.   EUROPEAN NEUROLOGY

Age-Dependent B Cell Autoimmunity to a Myelin Surface Antigen in Pediatric Multiple Sclerosis

(2009) K. A. McLaughlin et al.   JOURNAL OF IMMUNOLOGY

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET